Daunorubicin and gambogic acid co-loaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo by Zhou, Yi et al.
Daunorubicin and gambogic acid co-loaded cysteamine-CdTe
quantum dots minimizing the multidrug resistance of lymphoma
in vitro and in vivo
Zhou, Y., Wang, R., Chen, B., Sun, D., Hu, Y., & Xu, P. (2016). Daunorubicin and gambogic acid co-loaded
cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo.
International Journal of Nanomedicine, 2016(11), 5429-5442. DOI: 0.2147/IJN.S115037
Published in:
International Journal of Nanomedicine
Document Version:
Publisher's PDF, also known as Version of record
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
© 2016 Zhou et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at
https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-
nc/3.0/). By accessing the work you
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited,
provided the work is properly attributed. For permission
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:15. Feb. 2017
© 2016 Zhou et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php 
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you 
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission 
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
International Journal of Nanomedicine 2016:11 5429–5442
International Journal of Nanomedicine Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
5429
O r I g I N a l  r e s e a r c h
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/IJN.S115037
Daunorubicin and gambogic acid coloaded 
cysteamine-cdTe quantum dots minimizing the 
multidrug resistance of lymphoma in vitro and 
in vivo
Yi Zhou1,2
ruju Wang1
Bing chen1
Dan sun3
Yong hu2
Peipei Xu1
1Department of hematology, Drum 
Tower hospital, school of Medicine, 
2Institute of Materials engineering 
and collaborative Innovation center 
of chemistry for life sciences, 
college of engineering and applied 
sciences, Nanjing University, Nanjing 
People’s republic of china; 3school 
of Mechanical engineering, Queen’s 
University Belfast, Belfast, UK
Abstract: To minimize the side effects and the multidrug resistance (MDR) arising from 
daunorubicin (DNR) treatment of malignant lymphoma, a chemotherapy formulation of 
cysteamine-modified cadmium tellurium (Cys-CdTe) quantum dots coloaded with DNR and 
gambogic acid (GA) nanoparticles (DNR-GA-Cys-CdTe NPs) was developed. The physical 
property, drug-loading efficiency and drug release behavior of these DNR-GA-Cys-CdTe 
NPs were evaluated, and their cytotoxicity was explored by 3-[4,5-dimethylthiazol-2-y1]-2,5-
diphenyltetrazolium bromide assay. These DNR-GA-Cys-CdTe NPs possessed a pH-responsive 
behavior, and displayed a dose-dependent antiproliferative activity on multidrug-resistant lym-
phoma Raji/DNR cells. The accumulation of DNR inside the cells, revealed by flow cytometry 
assay, and the down-regulated expression of P-glycoprotein inside the Raji/DNR cells measured 
by Western blotting assay indicated that these DNR-GA-Cys-CdTe NPs could minimize the 
MDR of Raji/DNR cells. This multidrug delivery system would be a promising strategy for 
minimizing MDR against the lymphoma.
Keywords: daunorubicin, gambogic acid, Cys-CdTe QDs, multidrug resistance, non-Hodgkin’s 
lymphoma
Introduction
Malignant lymphoma is a group of primary malignant tumor in the lymph tissues, 
which can be divided into Hodgkin’s lymphoma (HL, 10%) and non-Hodgkin’s lym-
phoma (NHL, 90%) according to the clinical and pathological features.1 In the US, it 
was estimated that 20,940 people died from lymphoma (HL 1,150; NHL 19,790) in 
2015, and the mortality rate of NHL was ranked ninth in males and eighth in females 
for cancer-related deaths.2 Although, benefiting from the hematopoietic stem cell 
transplantation, treatment of refractory lymphoma greatly improved over the past 
few decades,3 chemotherapeutics are still the most effective treatment for malignant 
lymphoma.
Daunorubicin (DNR), an anthracycline antibiotic, has been used as a first-line 
chemotherapy component in the treatment of NHL.4,5 Despite its side effects, including 
cardiac toxicity and bone marrow suppression,6 the modest lipophicity and net posi-
tive charge at physiological pH made DNR an efficient substrate for P-glycoprotein 
(P-gp).7,8 P-gp is known to actively pump substrates out of tumor cells through an 
adenosine triphosphate, resulting in multidrug resistance (MDR) and hampering the 
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successful clinic application of DNR.9,10 To date, reducing 
the side effects of DNR and minimizing MDR still remain 
major challenges in the application of DNR.11
To minimize MDR in the treatment of tumor, innovative 
strategies, including novel delivery systems and effective 
sensitizers, were applied to selectively deliver the che-
motherapeutic drugs inside the tumor cells or improve the 
sensitivity of chemotherapy to strengthen the therapeutic 
efficacy.12 Among them, nanocarriers showed promising 
potential in minimizing P-gp-mediated MDR by extend-
ing the circulation time of drugs in vivo, delivering large 
amount of drugs to the targeting tissue, and releasing a high 
concentration of drugs inside the cells after they translocate 
on the cell membrane.13–15 In our previous report, gambogic 
acid (GA)-loaded cysteamine-modified cadmium tellurium 
quantum dots (GA-Cys-CdTe QDs) showed promising ability 
to improve drug accumulation in K562 cells and minimize 
MDR of the drug-resistant K562/A02 cells.16 GA not only 
shows significant anticancer activity in vitro and in vivo, 
but also is an attractive agent for the chemosensitization of 
cancer cells. Recent research shows that GA can decrease 
P-gp expression as well as reduce its activity, suggesting 
the potential of GA as a novel P-gp inhibitor.17 Codelivery 
of GA and docetaxel can restore the docetaxel sensitivity in 
gastric cancer cell lines and minimize the apoptotic defect of 
BGC-823/Doc cells.18 In addition, the codelivery of GA and 
DNR by polymeric nanoparticles could greatly increase the 
intracellular concentration of DNR and decrease the expres-
sion of P-gp, thus offering a promising solution to minimize 
MDR and promote anticancer efficiency.
In this work, a multifunctional drug delivery system 
combined with GA, DNR, and Cys-CdTe QDs nanopar-
ticles (DNR-GA-Cys-CdTe NPs) was fabricated. CdTe QDs 
have unique optical properties and have been widely used 
in simultaneous molecular/tissue imaging, cell labelling, 
in vivo tumor detection, and drug delivery applications.19–21 
With the aid of surface modification with cysteamine, 
GA and DNR could be facilely loaded onto the CdTe 
QDs through electronic interaction, resulting in high drug 
loading. Furthermore, GA can effectively bind to transferrin 
receptor – a type of protein overexpressed on the surface of 
different cancer cells, providing GA an additional ability 
to target cancer cells.22 We hope these multifunctional 
DNR-GA-Cys-CdTe NPs can effectively deliver the drug, 
selectively bind to lymphoma cells, minimize MDR and 
monitor their intracellular distribution in real time (Figure 1). 
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Figure 1 schematic illustration of the structure of DNr-ga-cys-cdTe NPs.
Notes: These DNr-ga-cys-cdTe NPs can enter the cancer cells by endocytosis. Drugs can be released from DNr-ga-cys-cdTe NPs in the acidic environment of 
endosomes/lysosomes to exert the synergistic antitumor effect.
Abbreviations: cys, cysteamine; cdTe, cadmium-tellurium; DNr, daunorubicin; ePr, enhanced permeability and retention; ga, gambogic acid; NPs, nanoparticles.
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Their ability to enhance the antitumor effect of DNR and 
minimize MDR in lymphoma cells Raji and drug-resistant 
cell line Raji/DNR were studied.
Materials and methods
reagents and animals
GA (Kanion Pharmaceutical Co., Ltd, Lianyungang, 
People’s Republic of China) was dissolved in dimethyl 
sulfoxide (Sigma-Aldrich Co., St Louis, MO, USA), and 
stored at -20°C. Daunorubicin hydrochloride (DNR⋅HCl) 
(Hisun Pharmaceutical Co., Ltd, Taizhou, People’s Repub-
lic of China) was stored at 4°C. Cys-CdTe QDs were 
prepared as described elsewhere,23 and was ultrasonicated 
for 5 minutes before use. Roswell Park Memorial Institute 
(RPMI) 1640 medium was purchased from Gibco Chemical 
Co. (Carlsbad, CA, USA) and fetal bovine serum from Wisent 
Inc. (Montreal, QC, Canada). 3-[4,5-Dimethylthiazol-2-y1]-
2,5-diphenyltetrazolium bromide (MTT) and dimethyl 
sulfoxide were obtained from Sigma-Aldrich Co. Giemsa 
staining solution and 4,6-diamidino-2-phenylindole stain-
ing solution were purchased from Beyotime Institute of 
Biotechnology (Nanjing, People’s Republic of China). The 
cytotoxicity assay kit and Annexin V-fluorescein isothiocya-
nate apoptosis detection kit were obtained from Beyotime 
Biotechnology Co., Ltd. (Nantong, People’s Republic of 
China). The lymphoblastoid cells were derived from a 
Burkitt lymphoma and the resistant cell line to doxoru-
bicin, Raji, and Raji/DNR were provided by the Institute 
of Hematology, Chinese Academy of Medical Sciences. 
Standard amino acids, including aspartic acid, glutamic 
acid, γ-aminobutyric acid, and glycine were purchased from 
Sigma (Santa Clara, CA, USA). The hematoxylin–eosin 
kit was from KeyGen Biotech Co. Ltd. (Nanjing, People’s 
Republic of China). The mouse monoclonal antibodies for 
Bax, Bcl-2, caspase-3, P-gp, and β-actin were purchased 
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, 
USA). All regents used in this study were of analytical 
grade. BALB/c mice, BALB/c-nude mice, and Sprague 
Dawley rats were purchased from the Shanghai National 
Center for Laboratory Animals (Shanghai, People’s 
Republic of China) in equal numbers of males and females. 
BALB/c mice and BALB/c-nude mice were 6 weeks old 
and weighed 18–22 g. Sprague Dawley rats were 7 weeks 
old and weighed 240–250 g. They were maintained in 
specific pathogen-free facilities. All animal experiments 
were performed in accordance with the Animal and Ethics 
Review Committee of the Affiliated Drum Tower Hospital 
of Nanjing University Medical School (Nanjing, People’s 
Republic of China).
synthesis and characterization of DNr-
cys-cdTe and DNr-ga-cys-cdTe NPs
The DNR⋅HCl was efficiently absorbed onto Cys-CdTe 
QDs via an electrostatic interaction. Briefly, 0.1 mL of 
DNR⋅HCl (1 mg/mL) and 0.05 mL of Cys-CdTe QDs 
(2.55×10-5 M, calculated according to the literature)24 were 
added to 0.85 mL deionized water and stirred for 22 hours 
at room temperature in the dark. After being centrifugated at 
16,000 rpm for 20 minutes to separate the DNR laden 
Cys-CdTe NPs, the supernatant DNR was analyzed by 
fluorescence spectrophotometer (F-4600, Hitachi, Tokyo, 
Japan). The precipitation was washed three times with deion-
ized water to remove the excess unreacted DNR, and the 
obtained samples were named as DNR-Cys-CdTe NPs.25
For the synthesis of DNR-GA-Cys-CdTe NPs, 0.1 mL 
of DNR⋅HCl (1 mg/mL) and 0.05 mL of Cys-CdTe QDs 
(2.55×10-5 M) were added to 0.8 mL of deionized water, 
and the mixture was stirred for 6 hours. Then, 0.05 mL of 
GA (1 mg/mL) was added and the mixture was stirred for 
another 16 hours. The separation procedures were the same 
as the synthesis of DNR-Cys-CdTe NPs.
To characterize the DNR-Cys-CdTe and DNR-GA-Cys-
CdTe NPs, the ultraviolet-visible absorption spectra were 
obtained using an ultraviolet-visible spectrophotometer 
(UV-3600, Shimadzu, Tokyo, Japan). Fourier transform infra-
red spectra were recorded on a Nicolet iS10 IR spectrometer 
(Thermo Scientific, Waltham, MA, USA) in the range of 
400–4,000 cm-1, using blank potassium bromide pellet as 
background. The transmission electron microscopy images 
were taken by a JEM-2100 transmission electron microscope 
(JEOL, Tokyo, Japan). The hydrodynamic diameters and size 
distribution of DNR-GA-Cys-CdTe NPs was measured by 
dynamic light scattering with a Zetasizer NanoZS size ana-
lyzer (Nano ZS90, Malvern Instruments, Malvern, UK).
The drug-loading and encapsulation efficiencies were 
calculated as follows:
 
Loading
efficiency
Weight of the drug in NPs
Weight of the N
=
Ps
×100%
 
 
 
Encapsulation
efficiency
Weight of the drug in NPs
Primary 
=
weight of the drug
×100%
 
In vitro release from DNr-ga-cys-cdTe 
NPs
In this work, the GA was used as a chemosensitizer to 
enhance the antitumor effect of DNR. Thus, only the release 
of DNR from DNR-GA-Cys-CdTe NPs was measured at 
pH 6.0 (typical pH of the environment around the tumor) 
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and pH 7.4 (pH of physiological blood), respectively. The 
DNR-GA-Cys-CdTe NPs (2.55×10-5 M) were dispersed in 
1 mL of phosphate-buffered saline (PBS) and transferred into 
a dialysis bag (molecular weight cutoff of 3,500 Da), which 
was immersed in 5 mL of PBS of pH 6.0 and 7.4, followed by 
continuous shaking (100 rpm) at 37°C. At predetermined time 
intervals, aliquots (0.2 mL) were removed from the buffer 
solution and an equivalent volume of fresh buffer solution 
was compensated. The amount of DNR released was then 
determined by fluorescence spectrophotometer.26
cell cultures
Human embryonic lung fibroblast (HELF), human 
lymphoma-resistant cell line to DNR, Raji/DNR, and 
lymphoma Raji cells (Shanghai Institute of Cells, Chinese 
Academy of Sciences, Shanghai, People’s Republic of 
China) were grown in RPMI 1640 medium supplemented 
with 10% (v/v) heat-inactivated fetal bovine serum, 10 mM 
4-[2-hydroxyethyl]-1-piperazineethanesulfonic acid, 100 U/
mL penicillin, and 100 μg/mL streptomycin in 5% CO
2
 and 
95% air at 37°C in a humidified incubator. To maintain the 
drug resistance, Raji/DNR was incubated in a culture contain-
ing 1 μg/mL DNR⋅HCl at least 1 week before use.
cytotoxicity studies of cys-cdTe QDs 
and ga for helF or raji/DNr cells 
in vitro
MTT assay was used to detect the cytotoxicity and the range 
of safe concentration of Cys-CdTe QDs and GA. Five-minute 
sonication of Cys-CdTe QDs were performed before the 
following experiments. Different concentrations of GA 
(0.25, 0.5, 1, or 2 μg/mL) or Cys-CdTe QDs (2.5, 5, 10, or 
20 nmol) were added to HELF or Raji/DNR cells. Then, 
these cells were seeded in 96-well plates containing 100 μL 
of 2×105 cells suspension and each concentration was set in 
three wells. In addition, cells added with saline were set as 
control. After 4 hours of incubation, the adherence appeared. 
Then, 100 μL solution of Cys-CdTe QDs or GA were added 
to the suspension and incubated at 37°C for 24 hours. After 
that, 20 μL, 5 mg/mL MTT solution was added to the suspen-
sion and cultured for another 4 hours before centrifugation 
at 1,000 rpm for 10 minutes. At last, 150 μL of dimethyl 
sulfoxide was added to each well and the plates were shaken 
with a micro-oscillator to dissolve the crystals. An optical 
density of 540 nm was measured on a microplate reader 
(Multiskan MK3, Thermo Scientific, Boston, MA, USA), 
and the relative growth rate was calculated. Every experiment 
was repeated at least three times.
Intracellular accumulation of DNr
Intracellular accumulation of DNR was directly detected by 
flow cytometry (FCM). Briefly, the Raji/DNR cells were 
treated as formerly described (described in ‘Cell cultures’). 
After being incubated with 100 μL DNR (2 μg/mL), 
GA+DNR (GA:DNR =1:4 w/w), DNR-Cys-CdTe NPs, or 
DNR-GA-Cys-CdTe NPs (the concentration of DNR was 
2 μg/mL) for 48 hours, the cells were washed three times with 
PBS and then suspended in 500 μL of PBS. Each sample was 
measured by FCM (BD FACSAria [TM II]; Becton Dickinson, 
Franklin Lakes, NJ, USA) at excitation/emission wavelengths 
of 488/575 nm. The relative fluorescence intensity of DNR 
was computed as FI
treated
 group/FI
control
 group. The cells treated 
with RPMI 1640 alone were used as control groups.
cytotoxicity of different agents against 
raji and raji/DNr cells
After being cultured without drug for 2 weeks, the cells in 
the log phase were picked in culture flasks and collected 
by centrifugation in nutrient fluid. The obtained cells 
were then stained with trypan blue and living cells (more 
than 98%) were selected. According to the experiment, 
the cells were grouped as follows: A) the control group 
(saline group); B) DNR group; C) DNR-Cys-CdTe NPs 
group; D) DNR+GA group; and E) DNR-GA-Cys-CdTe NPs 
group. Every experiment was repeated at least three times.
The cells in log phase were cultured for 4 hours 
before 100 μL DNR (0.25–8.00 μg/mL for Raji cells 
and 0.25–50.0 μg/mL for Raji/DNR cells), GA+DNR 
(GA:DNR =1:4 w/w), DNR-Cys-CdTe NPs, or DNR-GA-
Cys-CdTe NPs of different concentrations were added to 
ensure the same dose of DNR. After incubation for 48 hours, 
to these cells were added 20 μL, 5 mg/mL MTT and they 
were cultured for another 4 hours. Optical density of 
540 nm (A540) was measured after the addition of dimethyl 
sulfoxide. The half maximal inhibitory concentration (IC
50
) 
was calculated according to the rate of growth inhibition.
Imaging of raji/DNr cells by confocal 
laser scanning microscopy
Raji/DNR cells (5×104/mL) were cultured in 5% CO
2
 at 37°C 
with DNR, Cys-CdTe QDs, or DNR-GA-Cys-CdTe NPs for 
12 hours before being gathered through centrifugation at 
1,000 rpm. After the medium was discarded, the cells were 
washed at least three times with PBS to remove the unbound 
drugs. Then, the obtained cell cultures were drop casted on 
a clean glass slide immediately, followed by the observa-
tion with a confocal laser scanning microscope (Fluo View 
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
3.
11
7.
19
3.
36
 o
n 
24
-O
ct
-2
01
6
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2016:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
5433
DNr and ga coloaded QDs overcoming MDr
FV1000, Olympus, Tokyo, Japan). Excitation of the DNR and 
Cys-CdTe QDs was performed with lasers at 488 and 350 nm, 
and emission spectra were collected using a wavelength range 
of 570–630 nm and 450–500 nm. All the optical measure-
ments were implemented at room temperature (25°C±2°C).
apoptosis of raji/DNr cells
Raji/DNR cells were cultured with DNR (2 μg/mL), 
GA+DNR (GA:DNR =1:4 w/w), or DNR-Cys-CdTe or 
DNR-GA-Cys-CdTe NPs of different concentrations to 
ensure the same dose of DNR. Cells in different groups were 
labelled with fluorescein isothiocyanate-conjugated Annexin 
V and propidium iodide by using the Annexin V-fluorescein 
isothiocyanate apoptosis detection kit in accordance with the 
manufacturer’s instructions.
cell morphological research
Raji/DNR cells were incubated in RPMI 1640 medium 
containing DNR, DNR+GA, DNR-Cys-CdTe or DNR-GA-
Cys-CdTe NPs (the same concentrations as Apoptosis of Raji/
DNR cells) at 37°C for 24 hours. Then, cells were washed 
three times in PBS and fixed with methanol for 15 minutes. 
After that, cells were stained with fluorochrome dye 4,6-
diamidino-2-phenylindole, and subsequently observed under 
a fluorescence microscope (Imager A1 AX10, Carl Zeiss, 
Jena, Germany) with an excitation wavelength of 340 nm.
Nude mouse model of MDr lymphoma 
xenograft
Thirty nude mice were injected subcutaneously with 0.2 mL 
of a DNR-resistant Raji cell suspension (1×107 cells). When 
the tumor size reached 80–150 mm3, the mice were randomly 
allocated to five groups: group a (saline as negative control), 
group b (DNR), group c (DNR+GA), group d (DNR-Cys-CdTe 
NPs), and group e (DNR-GA-Cys-CdTe NPs). Each mouse 
was intravenously administered seven doses of 0.2 mL of the 
treatment agent on days 0, 2, 4, 6, 8, 10, and 12 (one dose 
per day). Based on the drug-loading efficiency, the DNR con-
centration was 1.2 mg/kg in each group except the control.
Measurement of tumor size and 
inhibition rate
The tumor length (a) and width (b) were measured every 
day using a caliper and the tumor volume was calculated as 
follows: V =1/2×a×b2. Relative tumor volume (RTV) was 
calculated as follows: RTV = Vx/V1, where V1 represents 
the volume on the first day of treatment and Vx represents the 
volume on day X. The inhibition rate, reflecting the antitumor 
effect, was calculated as follows: inhibition rate = (1– mean 
RTV of the experimental group/mean RTV of the control 
group) ×100%.
histopathological examination
After the mice were sacrificed, tumor tissues and organs, 
including the liver, kidneys, spleen, heart, and lung were iso-
lated from the mice and fixed and embedded. Tissue sections 
were prepared and stained with hematoxylin and eosin. Histo-
pathological changes were observed by optical microscopy.
Western blotting assay
The total proteins that would be used for western blotting 
measurement, were extracted from the tumor tissues of each 
animal group. Briefly, proteins were size fractionated by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis 
and then transferred to a polyvinylidene difluoride membrane. 
Blotting was performed using monoclonal antibodies (Bax, 
Bcl-2, caspase-3, P-gp), and 5% skimmed milk was used as 
a blocking agent. β-Actin was used to normalize the data.
Results
synthesis and characterization of 
DNr-ga-cys-cdTe NPs
DNR and GA can be loaded onto the Cys-CdTe QDs to 
create the DNR-GA-Cys-CdTe NPs due to the electrostatic 
interaction.27 The ultraviolet-vis absorption spectra of DNR, 
GA, Cys-CdTe QDs, and DNR-GA-Cys-CdTe NPs were 
measured and are shown in Figure 2A. Except the absorption of 
Cys-CdTe QDs at 460 nm, two characteristic absorption peaks 
for DNR (480 nm) and GA (360 nm) were clearly observed 
in the spectrum of DNR-GA-Cys-CdTe NPs, indicating that 
the DNR and GA were successfully absorbed by the Cys-
CdTe QDs. In addition, the formation of DNR-GA-Cys-CdTe 
NPs was confirmed by Fourier transform infrared spectros-
copy (Figure 2B). The absorption of DNR on the surface 
of Cys-CdTe QDs was substantiated by the presence of the 
characteristic bands of DNR at 1,716 and 1,284 cm-1, which 
corresponded to the C=O stretching vibration and the O–H 
bending vibration in the spectrum of DNR-GA-Cys-CdTe NPs. 
The characteristic band of GA at 1,680 cm-1 was also observed 
in the spectrum of DNR-GA-Cys-CdTe NPs and could be 
assigned to the C=C stretching vibration, further supporting 
the loading of GA. The above results show strong indication 
that DNR and GA coloaded DNR-GA-Cys-CdTe NPs have 
been obtained. The size, morphology, and size distribution 
of these DNR-GA-Cys-CdTe NPs were shown in Figure 2C 
and D. The DNR-GA-Cys-CdTe NPs exhibited very good 
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dispersibility in water. Although, some of the NPs aggregated 
when in dried state, the transmission electron microscopy image 
of DNR-GA-Cys-CdTe NPs showed spherical morphology 
with a size around 6 nm (Figure 2C). The average hydrody-
namic size of Cys-CdTe QDs obtained from the dynamic light 
scattering is 3.21 nm, and the average hydrodynamic size of 
DNR-GA-Cys-CdTe NPs is 7.2 nm (Figure 2D). The zeta 
potential demonstrates that after attachment of drug molecules 
to the surface of the Cys-CdTe quantum dots, the relevant zeta 
potential value changed from -20.4±4.1 to -10.3±2.3 mV.
Encapsulation efficiency and in vitro drug 
release behavior of DNr from DNr-ga-
cys-cdTe NPs
The high surface–volume ratio of Cys-CdTe QDs makes it 
easy to load them with a great quantity of DNR. After the 
encapsulation of DNR, the encapsulation efficiency and DNR 
release ability were measured (Table 1). The encapsulation 
efficiencies of DNR are 92.45%±0.85% (DNR-Cys-CdTe 
NPs) and 84.47%±1.35% (DNR-GA-Cys-CdTe NPs), 
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Figure 2 characterization of DNr-ga-cys-cdTe NPs.
Notes: (A) Ultraviolet-vis spectra of DNr, ga, cys-cdTe QDs, and DNr-ga-cys-cdTe NPs; (B) Fourier transform infrared spectra of DNr-ga-cys-cdTe NPs, ga, 
DNr-cys-cdTe NPs, DNr, and cys-cdTe QDs; (C) TeM images of DNr-ga-cys-cdTe NPs; (D) Dls analysis of DNr-ga-cys-cdTe NPs.
Abbreviations: cys, cysteamine; cdTe, cadmium-tellurium; Dls, dynamic light scattering; DNr, daunorubicin; ePr, enhanced permeability and retention; ga, gambogic acid; 
NPs, nanoparticles; QDs, quantum dots; TeM, transmission electron microscopy.
Table 1 Encapsulation efficiency and loading efficiency of DNR and GA on DNR-Cys-CdTe NPs or DNR-GA-Cys-CdTe NPs
DNR GA
Encapsulation efficiency (%) Loading efficiency (%) Encapsulation efficiency (%) Loading efficiency (%)
DNr-cys-cdTe NPs 92.45±0.85 48.04±0.44 – –
DNr-ga-cys-cdTe NPs 84.47±1.35 40.04±0.64 26.49±0.92 12.56±0.44
Abbreviations: cys, cysteamine; cdTe, cadmium-tellurium; DNr, daunorubicin; ga, gambogic acid; NPs, nanoparticles.
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confirming that Cys-CdTe QDs can be used as efficient 
anticancer drug carriers. Because of the presence of GA, the 
encapsulation efficiencies of DNR slightly decreased in the 
DNR-GA-Cys-CdTe NPs.
The DNR release from the DNR-GA-Cys-CdTe NPs 
was performed in the medium with different pH values 
(Figure 3). The release of DNR depended on the pH of 
the media, as well as the time. The release rate of DNR at 
pH 7.4 was comparatively slow, and only 30% of the DNR 
was released from the DNR-GA-Cys-CdTe NPs within 
24 hours. But at pH 6.0, the release of DNR was more 
rapid, and approximately 90% of DNR was released into 
the medium within 24 hours, indicating that the release of 
DNR from DNR-GA-Cys-CdTe NPs was pH-triggered. 
This result is quite interesting since the physiological con-
dition of blood is neutral with a pH of 7.4. Consequently, 
most of the DNR will remain stable on the surface of the 
DNR-GA-Cys-CdTe NPs when they are injected into the 
plasma, which largely reduces the side effects of DNR 
on the normal cells/tissues during the blood circulation. 
Due to the enhanced permeability and retention effect, 
these long-circulation NPs can be passively targeted to the 
tumor tissue with acidic microenvironment, resulting in a 
faster drug release. Therefore, an efficient DNR release and 
accumulation in the target tumor tissues can be obtained. 
Moreover, GA can effectively bind to transferrin receptor, 
suggesting that GA may be able to target cancer cells in 
cancer therapy. In this study, the presence of GA offered 
DNR-GA-Cys-CdTe NPs the additional ability to bind to 
cancer cells, which could accelerate the cellular uptake of 
these NPs. After being taken up by the tumor cells via an 
endocytosis process, because of the low pH value inside 
the endocytic compartments (pH from 4.5 to 6.5), a much 
faster DNR release was obtained. Therefore, a sufficiently 
high concentration of DNR could be obtained inside the 
tumor cells within a short period of time, which also helped 
to minimize MDR.
cytotoxicity of cys-cdTe QDs and ga 
for helF and raji/DNr cells
Prior to in vivo application, the cytotoxicity of Cys-CdTe 
QDs and GA was tested by MTT assay. Although, QDs 
were thought not to be biocompatible and had cytotoxicity 
at high concentrations, the Cys-CdTe QDs showed an inhibi-
tion ,10% against HELFs in the test concentration ranging 
from 2.5 to 10 nmol. Increasing the concentration to 20 nmol 
resulted in a lower cell viability of ,80%, which indicated 
that Cys-CdTe QDs could be safely used at a concentra-
tion ,20 nmol. On the other hand, in this study, GA was 
used as a sensitizer to improve the sensitivity of DNR and 
strengthen the therapeutic efficacy against the lymphoma. 
However, GA also showed significant anticancer activity 
in vitro and in vivo with high dose, which would interfere 
with the antitumor effect of DNR. So in order to avoid the 
inhibitory effect of GA on the tumor cells, the maximum 
concentration of GA, which could maintain its sensitive effect 
and avert the antitumor ability, was tested. Figure 4 shows the 
cytotoxicity of GA against HELF and Raji/DNR cells with 
different concentrations. The GA showed a dose-dependent 
cytotoxicity. The treatment of HELF and Raji/DNR cells with 
2.0 μg/mL of GA did not bring significant inhibition effect 
on the cells (P.0.05). Thus, the highest concentrations of 
GA and Cys-CdTe QDs were chosen to be ,0.5 μg/mL and 
20 nmol, respectively, which would impose little side effect 
on the proliferation of the HELFs.
Intracellular accumulation of DNr
The cellular uptake of different NPs samples was measured 
by FCM. Figure 5 shows the concentration of DNR in the 
Raji/DNR cells after these cells were incubated with dif-
ferent samples for 48 hours. Compared with the control 
group whose fluorescence intensity was defined as 1, the 
relative fluorescence intensities are 9.34±1.73, 16.75±1.47, 
14.66±2.98, and 26.37±2.28 for DNR, DNR+GA, DNR-Cys-
CdTe, and DNR-GA-Cys-CdTe NPs groups, respectively. 
These results indicated that by coloading GA and DNR 
onto the Cys-CdTe QDs, the highest concentration of DNR 
was detected in the Raji/DNR cells treated with DNR-GA-
Cys-CdTe NPs, indicating that the presence of GA could 
strengthen the cellular uptake of DNR-GA-Cys-CdTe NPs.
???
????
????
????
???
????
?? ??????????
?
??
??
??
??
???
? ?? ?? ?? ??
??????
??????
Figure 3 DNr release behavior from DNr-ga-cys-cdTe NPs at ph 7.4 and 
ph 6.0.
Abbreviations: cys, cysteamine; cdTe, cadmium-tellurium; DNr, daunorubicin; 
ga, gambogic acid; NPs, nanoparticles.
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Figure 4 The cytotoxicity of ga (A) or cys-cdTe QDs (B) for helF and raji/DNr cells with different concentration in 24 hours (P.0.05).
Abbreviations: Cys, cysteamine; CdTe, cadmium-tellurium; DNR, daunorubicin; GA, gambogic acid; HELF, human embryonic lung fibroblast; QDs, quantum dots. 
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Figure 5 Intracellular accumulation of DNr with different treatment evaluated by FcM (P,0.05).
Notes: (A) control; (B) DNr; (C) DNr+ga; (D) DNr-cys-cdTe NPs; (E) DNr-ga-cys-cdTe NPs; (F) relative fluorescence intensity (RFI) of DNR in Raji/DNR cells; 
sol: DNr or DNr+ga alone.
Abbreviations: Cys, cysteamine; CdTe, cadmium-tellurium; DNR, daunorubicin; FCM, flow cytometry; GA, gambogic acid; NPs, nanoparticles.
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cytotoxicity of different agents for raji 
and raji/DNr cells
The cytotoxicity of DNR, DNR-Cys-CdTe NPs, DNR+GA, 
and DNR-GA-Cys-CdTe NPs against lymphoma cells was 
measured, and results are shown in Figure 6A. For the 
Raji cells treated with different samples, cytotoxicity was 
dose-dependent and almost the same in the tested concen-
tration. But for the drug-resistant Raji/DNR cells, DNR 
had the lowest cytotoxicity while DNR-GA-Cys-CdTe 
NPs exhibited the highest cytotoxicity (Figure 6B). The 
IC
50
 of DNR, DNR-Cys-CdTe NPs, DNR+GA, and DNR-
GA-Cys-CdTe NPs in Raji/DNR cells was 20.128, 7.762, 
3.043, and 1.255 μg/mL, respectively, which confirmed that 
the cytotoxicity of DNR against the drug-resistant human 
lymphoma cells was notably enhanced with the presence of 
Cys-CdTe QDs and GA.
Fluorescence imaging and cellular labeling
Compared with traditional organic dyes, QDs have unique 
advantages as fluorescence probes. We further explored 
the cellular labeling and imaging functions of DNR-GA-
Cys-CdTe NPs. Raji/DNR cells were incubated with DNR, 
Cys-CdTe QDs, and DNR-GA-Cys-CdTe NPs and then 
examined by confocal microscope. As shown in Figure 7, 
after incubation with Cys-CdTe QDs, the weak blue fluores-
cence in the lymphoma cells was easily caught by confocal 
laser scanning microscopy, indicating successful penetration 
of Cys-CdTe QDs into Raji/DNR cells. Moreover, when 
treated with DNR-GA-Cys-CdTe NPs, the lymphoma cells 
could be clearly observed through fluorescence of these NPs 
(Figure 7D). Since GA molecules had no fluorescence and 
the fluorescent background of the cell had been removed, 
the intracellular fluorescence was only produced by DNR 
and Cys-CdTe QDs.28 In addition, the presence of multiple 
purple spots in the overlap image from DNR channel (red) 
and Cys-CdTe QDs channel (blue) clearly indicates that 
DNR is loaded on Cys-CdTe QDs and the appearance 
of DNR and GA did not influence the fluorescence of 
Cys-CdTe QDs. All the results suggested that it may be 
possible to use DNR-GA-Cys-CdTe NPs in cancer therapy 
as well as nanoprobes for real-time labeling and imaging 
of cancer cells.
apoptosis of raji/DNr cells
FCM was used to quantitatively investigate the apoptosis 
of Raji/DNR cells (Figure 8). After being incubated 
for 48 hours, the total apoptosis of Raji/DNR cells was 
2.94%±0.17% in the control group. Additionally, the apop-
tosis of cells in the DNR group increased to 8.69%±0.36% 
but showed no significant difference with the blank group, 
suggesting that DNR cannot induce apoptosis of Raji/
DNR cells. When the cells were cultured with DNR+GA and 
DNR-Cys-CdTe NPs, the apoptosis increased to 28.80%±0.45% 
and 40.13%±2.30%, respectively. Furthermore, when Raji/
DNR cells were treated by DNR-GA-Cys-CdTe NPs, the rate 
of apoptosis increased to 50.55%±1.84%, which showed a 
significant change compared with the control group. These 
results proved that GA could increase the ability of DNR to 
induce apoptosis of Raji/DNR cells. Moreover, when DNR, 
with or without GA, was loaded on the surface of Cys-CdTe 
QDs, the apoptosis of cells remarkably increased, suggesting 
that Cys-CdTe QDs could be used as a drug delivery system.
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Figure 6 Inhibition profiles of DNR, DNR-Cys-CdTe NPs, DNR+ga, and DNr-ga-cys-cdTe NPs for (A) raji and (B) raji/DNr cells. 
Notes: Ic50 of DNr, DNr-cys-cdTe NPs, DNr+ga, and DNr-ga-cys-cdTe NPs for (A) raji (P.0.05) and (B) raji/DNr cells (P,0.05).
Abbreviations: cys, cysteamine; cdTe, cadmium-tellurium; DNr, daunorubicin; ga, gambogic acid; NPs, nanoparticles.
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Figure 7 Confocal fluorescence microscopy images of Raji/DNR cells QDs.
Notes: (A) control; (B) DNr; (C) cys-cdTe QDs; (D) DNr-ga-cys-cdTe NPs. scale bar =10 μm.
Abbreviations: cys, cysteamine; cdTe, cadmium-tellurium; DNr, daunorubicin; ga, gambogic acid; NPs, nanoparticles; QDs, quantum dots.
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cancer cell apoptosis induced by 
DNr-ga-cys-cdTe NPs
The morphological changes of these drug-resistant Raji/DNR 
cells were further explored to study cancer cell apoptosis using 
fluorescent microscopy. As shown in Figure 9A, Raji/DNR 
cells in the control group emitted blue fluorescence, which 
was homogeneously dispersed inside the nucleus without 
remarkable cellular morphology variation, indicating no 
occurrence of apoptosis. After these cells were treated with 
DNR (Figure 9B or DNR+GA, the fluorescence intensity of 
4,6-diamidino-2-phenylindole inside nucleus became stronger, 
but the increase of apoptosis was not significant. However, 
after incubation with DNR-Cys-CdTe NPs (Figure 9D) or 
DNR-GA-Cys-CdTe NPs (Figure 9E) for 24 hours, these 
Raji/DNR cells emitted much stronger/brighter fluorescence 
inside the nucleus, and the typical phenomena of apoptosis, 
including nucleolus pyknosis, chromatin condensation, and 
nuclear fragmentation were clearly observed (indicated by 
red arrows). Also, the cells ruptured and were unable to 
maintain their normal shape (Figure 9E). These observations 
attested the synergistic anticancer effect due to the codelivery 
of GA and DNR by DNR-GA-Cys-CdTe NPs. Higher amount 
of DNR delivered into the lymphoma cells by such a system 
can result in higher cytotoxicity, which consequently inhibits 
cellular proliferation.
evaluation of tumor inhibition in a 
nude mouse model of MDr lymphoma 
xenograft
Over the course of 14 days posttreatment, the nude mice were 
in good condition without obvious adverse reactions. As 
shown in Figure 10, the tumor volume decreased gradually 
in the DNR-Cys-CdTe- and the DNR-GA-Cys-CdTe-treated 
groups, and the RTVs in these two groups were smaller 
than those of the other three groups (P,0.05), especially 
in the DNR-GA-Cys-CdTe group (P,0.01) (Figure 10). 
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Figure 8 The apoptosis of raji/DNr cells with different treatment evaluated by FcM.
Notes: (A) control; (B) DNr; (C) DNr+ga; (D) DNr-cys-cdTe NPs; (E) DNr-ga-cys-cdTe NPs.
Abbreviations: Cys, cysteamine; CdTe, cadmium-tellurium; DNR, daunorubicin; FCM, flow cytometry; FITC, fluorescein isothiocyanate; GA, gambogic acid; NPs, 
nanoparticles.
At day 6 posttreatment, the tumor inhibition rates in the 
DNR-GA-Cys-CdTe, DNR-Cys-CdTe, DNR+GA, and 
DNR groups were 87.29%±3.77%, 58.49%±3.65%, 
22.02%±5.22%, and 9.33%±0.58% (Figure 10C), respectively, 
suggesting that DNR-GA-Cys-CdTe NPs had the highest 
tumor inhibition ability. Tumor tissues were isolated after the 
mice were sacrificed. DNR-GA-Cys-CdTe NPs-treated group 
had the smallest tumor among all the samples (Figure 10A), 
indicating that DNR-GA-Cys-CdTe NPs could suppress tumor 
growth and enhance the antitumor activity of DNR.
histopathological examination
In the saline and DNR groups, the isolated tumor tissues 
presented a ruddy appearance with abundant blood supply, 
and tumor cells appeared in a disordered arrangement, with 
different sizes, heterogeneous cell types, numerous mitoses, 
and large hyperchromatic nuclei upon histopathological 
examination. In contrast, sheet necrosis and few neovessels 
were observed in the DNR-Cys-CdTe NPs- and DNR-GA-
Cys-CdTe NPs-treated groups (Figure 10B).
expressions of Bax, Bcl-2, caspase-3, and 
P-gp in tumor tissues
Western blotting was performed to detect the protein 
expression of Bax, Bcl-2, caspase-3, and P-gp in tumor 
tissues (Figure 11). There was no significant difference for 
all detected proteins between the saline and DNR groups 
(P.0.05), but all protein expression levels in the DNR+GA 
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Figure 10 Tumor inhibition in a nude mouse model of DNr-resistant raji xenograft after treatment.
Notes: (A) Isolated tumor bodies. (B) histopathological examination of tumor tissues in the mouse model at day 12 posttreatment (hematoxylin and eosin staining, ×40). 
(C) Tumor inhibition rates of different groups; (D) relative tumor volumes of different treatments: saline; DNr; DNr+ga; DNr-cys-cdTe NPs; DNr-ga-cys-cdTe NPs.
Abbreviations: cys, cysteamine; cdTe, cadmium-tellurium; DNr, daunorubicin; ga, gambogic acid; NPs, nanoparticles.
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Figure 9 Fluorescence microscope images of (A) control, (B) DNr, (C) DNr+ga, (D) DNr-cys-cdTe, and (E) DNr-ga-cys-cdTe NPs. (400×).
Note: The typical phenomena of apoptosis were indicated by red arrows.
Abbreviations: cys, cysteamine; cdTe, cadmium-tellurium; DNr, daunorubicin; ga, gambogic acid; NPs, nanoparticles.
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Figure 11 The expressions of apoptosis-related proteins (Bax, Bcl-2, and caspase-3) 
and P-gp after treatment. 1, saline; 2, DNr; 3, DNr+ga; 4, DNr-cys-cdTe NPs; 
5, DNr-ga-cys-cdTe NPs. The results were normalized by β-actin expression.
Abbreviations: cys, cysteamine; cdTe, cadmium-tellurium; DNr, daunorubicin; 
ga, gambogic acid; NPs, nanoparticles.
?????????
????
? ? ? ? ?
?????
???
β??????
group were significantly different from the saline and DNR 
groups (P,0.05). In the DNR-Cys-CdTe and DNR-GA-Cys-
CdTe groups, Bax and caspase-3 were strongly expressed, 
while the expression of Bcl-2 and P-gp decreased signifi-
cantly (P,0.05), which resulted in an elevated ratio of Bax/
Bcl-2 (P,0.01) compared with those of the other groups.
Discussion
Although systemic chemotherapy is still the main therapy 
option for NHL, drug-resistant cells usually lead to the 
therapy failure. P-gp plays an important role in develop-
ing chemotherapeutic resistance because it can pump 
anticancer drugs out of the cellular membrane.29 A lot of 
chemotherapeutic agents (anthracyclines or paclitaxel) have 
been testified to induce drug resistance via overexpressing 
P-gp, which is the main mechanism of MDR.30 A variety of 
compounds (MDR reversal agents) are applied to interfere 
with P-gp function. Such agents may improve the efficacy 
of conventional therapy when they are used in combination 
with anticancer drugs. As a chemotherapy sensitization 
agent, GA can inhibit the activation of nuclear factor-κB 
and increase the accumulation of anticancer drugs inside 
cells through downregulating the level of P-gp. Besides, 
nanotechnology also holds promising potential to minimize 
MDR and decrease the side effects in the cancer therapy.31 
In this work, DNR-GA-Cys-CdTe NPs were fabricated with 
the aim to minimize P-gp-mediated MDR in Raji/DNR cells. 
Compared with coadministration of a MDR reversal agent 
and an anticancer drug, coloading of GA and DNR onto 
nanoparticles can deliver these drugs locally and simultane-
ously, thus maximizing the therapeutic effect.32
The in vitro drug release of DNR from DNR-GA-
Cys-CdTe NPs was pH sensitive. Considering the acidic 
microenvironment around in the tumor tissue and inside 
the subcellular organelle (endosome, lysosome), most of 
the loaded DNR would be released in the tumor or inside the 
tumor cells, while imposing less side effects of DNR on the 
normal tissue. The highest relative fluorescence intensity of 
DNR inside the cells treated with DNR-GA-Cys-CdTe NPs 
also proved that presence of GA significantly increased the 
intracellular concentration of DNR, resulting in the highest 
growth inhibition efficiency. The antitumor effect on nude 
mice also showed that DNR-GA-Cys-CdTe NPs had the best 
tumor inhibition. The results of Western blot confirmed the 
lowest level of P-gp in the Raji/DNR cells treated by DNR-
GA-Cys-CdTe NPs, clearly indicating the ability of GA to 
reverse the MDR effect of Raji/DNR cells through inhibiting 
the expression of P-gp on the cell membrane.
Conclusion
In summary, DNR-GA-Cys-CdTe NPs were prepared and 
used as multifunctional deliver platform to deliver DNR 
and trace cancer cells in cancer therapy. These DNR-GA-
Cys-CdTe NPs demonstrated good aqueous dispersion and 
efficient drug-loading ability. They could enable rapid drug 
release in an acidic environment and induce excellent antitu-
mor effect in vitro. It is evident that coloading of DNR and 
GA with Cys-CdTe QDs can significantly increase DNR 
accumulation inside the drug-resistant Raji/DNR cells, and 
thus increase the cytotoxicity of DNR. Above all, these 
DNR-GA-Cys-CdTe NPs are able to minimize the MDR of 
Raji/DNR cells and efficiently inhibit the proliferation of 
cancer cells. This formulation will be a promising strategy for 
minimizing MDR and open a new avenue toward systemic 
chemotherapy for NHL.
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